Chemokine alpha 2
    1.
    发明授权
    Chemokine alpha 2 失效
    趋化因子α2

    公开(公告)号:US06479633B1

    公开(公告)日:2002-11-12

    申请号:US09238184

    申请日:1999-01-27

    IPC分类号: C07K100

    摘要: Human chemokine Alpha-2 polypeptides and DNA (RNA) encoding such chemotactic cytokines and a procedure for producing such polypeptides by recombinant techniques is disclosed. Also disclosed are methods for utilizing such chemotactic cytokines for the treatment of leukemia, tumors, chronic infections, auto-immune disease, fibrotic disorders, wound healing and psoriasis. Antagonists against such chemotactic cytokines and their use as a therapeutic to treat rheumatoid arthritis, autoimmune and chronic and acute inflammatory and infective diseases, allergic reactions, prostaglandin-independent fever and bone marrow failure are also disclosed. Also disclosed are diagnostic assays for detecting diseases related to mutations in the nucleic acid sequences and altered concentrations of the polypeptides. Also disclosed are diagnostic assays for detecting mutations in the polynucleotides encoding the chemotactic cytokines and for detecting altered levels of the polypeptides in a host.

    摘要翻译: 公开了人趋化因子α-2多肽和编码这种趋化性细胞因子的DNA(RNA)以及通过重组技术产生此类多肽的方法。 还公开了利用这种趋化性细胞因子治疗白血病,肿瘤,慢性感染,自身免疫疾病,纤维化病症,伤口愈合和牛皮癣的方法。 还公开了抗这种趋化性细胞因子的拮抗剂及其作为治疗类风湿性关节炎,自身免疫性和慢性和急性炎性和感染性疾病,过敏反应,前列腺素不依赖性发烧和骨髓衰竭的治疗剂的用途。 还公开了用于检测与核酸序列中的突变和多肽的改变的浓度相关的疾病的诊断测定。 还公开了用于检测编码趋化性细胞因子的多核苷酸中的突变并用于检测宿主中多肽的改变水平的诊断测定法。

    Chemokine alpha-2 antibodies
    2.
    发明授权
    Chemokine alpha-2 antibodies 失效
    趋化因子α-2抗体

    公开(公告)号:US07122639B2

    公开(公告)日:2006-10-17

    申请号:US10267900

    申请日:2002-10-10

    摘要: Human chemokine Alpha-2-polypeptides and DNA (RNA) encoding such chemotactic cytokines and a procedure for producing such polypeptides by recombinant techniques is disclosed. Also disclosed are method for utilizing such chemotactic cytokines for the treatment of leukemia, tumors, chronic infections, auto-immune disease, fibrotic disorders, wound healing and psoriasis. Antagonists against such chemotactic cytokines and their use as a therapeutic to treat rheumatoid arthritis, autoimmune and chronic and acute inflammatory and infective diseases, allergic reactions, prostaglandin-independent fever and bone marrow failure are also disclosed. Also disclosed are diagnostic assays for detecting diseases related to mutations in the nucleic acid sequences and altered concentrations of the polypeptides. Also disclosed are diagnostic assays for detecting mutations in the polynucleotides encoding the chemotactic cytokines and for detecting altered levels of the polypeptides in a host.

    摘要翻译: 公开了人趋化因子α-2-多肽和编码这种趋化性细胞因子的DNA(RNA)以及通过重组技术产生此类多肽的方法。 还公开了利用这种趋化性细胞因子治疗白血病,肿瘤,慢性感染,自身免疫疾病,纤维化病症,伤口愈合和牛皮癣的方法。 还公开了抗这种趋化性细胞因子的拮抗剂及其作为治疗类风湿性关节炎,自身免疫性和慢性和急性炎性和感染性疾病,过敏反应,前列腺素不依赖性发烧和骨髓衰竭的治疗剂的用途。 还公开了用于检测与核酸序列中的突变和多肽的改变的浓度相关的疾病的诊断测定。 还公开了用于检测编码趋化性细胞因子的多核苷酸中的突变并用于检测宿主中多肽的改变水平的诊断测定法。

    Polynucleotides encoding chemokine .alpha.-2
    3.
    发明授权
    Polynucleotides encoding chemokine .alpha.-2 失效
    编码趋化因子α的多核苷酸

    公开(公告)号:US5910431A

    公开(公告)日:1999-06-08

    申请号:US825556

    申请日:1997-03-19

    摘要: Human chemokine Alpha-2 polypeptides and DNA (RNA) encoding such chemotactic cytokines and a procedure for producing such polypeptides by recombinant techniques is disclosed. Also disclosed are methods for utilizing such chemotactic cytokines for the treatment of leukemia, tumors, chronic infections, auto-immune disease, fibrotic disorders, wound healing and psoriasis. Antagonists against such chemotactic cytokines and their use as a therapeutic to treat rheumatoid arthritis, autoimmune and chronic and acute inflammatory and infective diseases, allergic reactions, prostaglandin-independent fever and bone marrow failure are also disclosed. Also disclosed are diagnostic assays for detecting diseases related to mutations in the nucleic acid sequences and altered concentrations of the polypeptides. Also disclosed are diagnostic assays for detecting mutations in the polynucleotides encoding the chemotactic cytokines and for detecting altered levels of the polypeptides in a host.

    摘要翻译: 公开了人趋化因子α-2多肽和编码这种趋化性细胞因子的DNA(RNA)以及通过重组技术产生此类多肽的方法。 还公开了利用这种趋化性细胞因子治疗白血病,肿瘤,慢性感染,自身免疫疾病,纤维化病症,伤口愈合和牛皮癣的方法。 还公开了抗这种趋化性细胞因子的拮抗剂及其作为治疗类风湿性关节炎,自身免疫性和慢性和急性炎性和感染性疾病,过敏反应,前列腺素不依赖性发烧和骨髓衰竭的治疗剂的用途。 还公开了用于检测与核酸序列中的突变和多肽的改变的浓度相关的疾病的诊断测定。 还公开了用于检测编码趋化性细胞因子的多核苷酸中的突变并用于检测宿主中多肽的改变水平的诊断测定法。

    Antibodies to natural killer cell activating factor II
    4.
    发明授权
    Antibodies to natural killer cell activating factor II 失效
    自然杀伤细胞激活因子II的抗体

    公开(公告)号:US07309780B2

    公开(公告)日:2007-12-18

    申请号:US11378243

    申请日:2006-03-20

    CPC分类号: C07K16/28 A61K38/00 C07K14/52

    摘要: The invention relates to NKAF II polypeptides, polynucleotides encoding the polypeptides, methods for producing the polypeptides, in particular by expressing the polynucleotides, and agonists and antagonists of the polypeptides. The invention further relates to methods for utilizing such polynucleotides, polypeptides, agonists and antagonists for applications, which relate, in part, to research, diagnostic and clinical arts.

    摘要翻译: 本发明涉及NKAF II多肽,编码多肽的多核苷酸,产生多肽的方法,特别是通过表达多核苷酸,多肽的激动剂和拮抗剂。 本发明还涉及用于应用的这些多核苷酸,多肽,激动剂和拮抗剂的方法,其部分涉及研究,诊断和临床领域。

    DNA encoding human natural killer cell activating factor II
    5.
    发明授权
    DNA encoding human natural killer cell activating factor II 失效
    编码人类天然杀伤细胞活化因子II的DNA

    公开(公告)号:US06448044B2

    公开(公告)日:2002-09-10

    申请号:US08832488

    申请日:1997-04-03

    IPC分类号: C12P2102

    CPC分类号: C07K16/28 A61K38/00 C07K14/52

    摘要: The invention relates to NKAF II polypeptides, polynucleotides encoding the polypeptides, methods for producing the polypeptides, in particular by expressing the polynucleotides, and agonists and antagonists of the polypeptides. The invention further relates to methods for utilizing such polynucleotides, polypeptides, agonists and antagonists for applications, which relate, in part, to research, diagnostic and clinical arts.

    摘要翻译: 本发明涉及NKAF II多肽,编码多肽的多核苷酸,产生多肽的方法,特别是通过表达多核苷酸,多肽的激动剂和拮抗剂。 本发明还涉及用于应用的这些多核苷酸,多肽,激动剂和拮抗剂的方法,其部分涉及研究,诊断和临床领域。

    Human cystatin F
    6.
    发明授权
    Human cystatin F 失效
    人类半胱氨酸蛋白酶抑制剂F

    公开(公告)号:US5919658A

    公开(公告)日:1999-07-06

    申请号:US832535

    申请日:1997-04-03

    摘要: The invention relates to cystatin F polypeptides, polynucleotides encoding the polypeptides, methods for producing the polypeptides, in particular by expressing the polynucleotides, and agonists and antagonists of the polypeptides. The invention further relates to methods for utilizing such polynucleotides, polypeptides, agonists and antagonists for applications, which relate, in part, to research, diagnostic and clinical arts.

    摘要翻译: 本发明涉及半胱氨酸蛋白酶抑制剂F多肽,编码多肽的多核苷酸,产生多肽的方法,特别是通过表达多核苷酸,多肽的激动剂和拮抗剂。 本发明还涉及用于应用的这些多核苷酸,多肽,激动剂和拮抗剂的方法,其部分涉及研究,诊断和临床领域。

    Human cystatin F antibodies
    7.
    发明授权
    Human cystatin F antibodies 有权
    人类半胱氨酸蛋白酶抑制剂F抗体

    公开(公告)号:US06576745B1

    公开(公告)日:2003-06-10

    申请号:US09528436

    申请日:2000-03-17

    IPC分类号: C07K1600

    摘要: The invention relates to Cystatin F polypeptides, polynucleotides encoding the polypeptides, methods for producing the polypeptides, in particular by expressing the polynucleotides, and agonists and antagonists of the polypeptides. The invention further relates to methods for utilizing such polynucleotides, polypeptides, agonists and antagonists for applications, which relate, in part, to research, diagnostic and clinical arts.

    摘要翻译: 本发明涉及半胱氨酸蛋白酶抑制剂F多肽,编码多肽的多核苷酸,产生多肽的方法,特别是通过表达多核苷酸,多肽的激动剂和拮抗剂。 本发明还涉及用于应用的这些多核苷酸,多肽,激动剂和拮抗剂的方法,其部分涉及研究,诊断和临床领域。

    Natural killer cell activating factor II
    9.
    发明授权
    Natural killer cell activating factor II 失效
    自然杀伤细胞激活因子II

    公开(公告)号:US07078482B2

    公开(公告)日:2006-07-18

    申请号:US10192611

    申请日:2002-07-11

    CPC分类号: C07K16/28 A61K38/00 C07K14/52

    摘要: The invention relates to NKAF II polypeptides, polynucleotides encoding the polypeptides, methods for producing the polypeptides, in particular by expressing the polynucleotides, and agonists and antagonists of the polypeptides. The invention further relates to methods for utilizing such polynucleotides, polypeptides, agonists and antagonists for applications, which relate, in part, to research, diagnostic and clinical arts.

    摘要翻译: 本发明涉及NKAF II多肽,编码多肽的多核苷酸,产生多肽的方法,特别是通过表达多核苷酸,多肽的激动剂和拮抗剂。 本发明还涉及用于应用的这些多核苷酸,多肽,激动剂和拮抗剂的方法,其部分涉及研究,诊断和临床领域。

    Methods of making chemokine alpha 3 antibodies
    10.
    发明授权
    Methods of making chemokine alpha 3 antibodies 失效
    制作趋化因子α3抗体的方法

    公开(公告)号:US07419662B2

    公开(公告)日:2008-09-02

    申请号:US10935306

    申请日:2004-09-08

    IPC分类号: A61K39/395 C07K16/10

    CPC分类号: C07K14/522

    摘要: Human chemokine Alpha-3 polypeptides and DNA (RNA) encoding such chemotactic cytokines and a procedure for producing such polypeptides by recombinant techniques is disclosed. Also disclosed are methods for utilizing such chemotactic cytokines for the treatment of leukemia, tumors, chronic infections, auto-immune disease, fibrotic disorders, sepsis, wound healing and psoriasis and to stimulate stem cell mobilization. Antagonists against such chemotactic cytokines and their use as a therapeutic to treat rheumatoid arthritis, auto-immune and chronic and acute inflammatory and infective diseases, allergic reactions, prostaglandin-independent fever, ARDS and bone marrow failure are also disclosed. Also disclosed are diagnostic assays for detecting diseases related to mutations in the nucleic acid sequences and altered concentrations of the polypeptides. Also disclosed are diagnostic assays for detecting mutations in the polynucleotides encoding the chemotactic cytokines and for detecting altered levels of the polypeptide in a host.

    摘要翻译: 公开了人趋化因子α-3多肽和编码这种趋化性细胞因子的DNA(RNA)和通过重组技术产生这种多肽的方法。 还公开了利用这种趋化性细胞因子治疗白血病,肿瘤,慢性感染,自身免疫疾病,纤维化病症,败血症,伤口愈合和牛皮癣并刺激干细胞移动的方法。 还公开了抗这种趋化性细胞因子的拮抗剂及其作为治疗类风湿性关节炎,自身免疫和慢性和急性炎性和感染性疾病,过敏反应,前列腺素依赖性发烧,ARDS和骨髓衰竭的治疗剂的用途。 还公开了用于检测与核酸序列中的突变和多肽的改变的浓度相关的疾病的诊断测定。 还公开了用于检测编码趋化性细胞因子的多核苷酸中的突变并用于检测宿主中多肽的改变水平的诊断测定。